张超（1982年- ），男，籍贯：河北省保定市，博士。2016年-2020年就读于河北大学化学与环境科学学院药物化学与分子诊断教育部重点实验室，2020年6月获得理学博士学位。2008年-2018年先后就职于成都地奥制药集团/中国科学院成都生物所、北京中生朗捷生物技术有限公司、北京泰格科信生物科技有限公司和河北博伦特药业有限公司，从事酶催化、诊断试剂研发、注册以及技术推广等工作。2020年11月到衡水学院生命科学学院任教。讲授酶工程、生物活性物质分离技术、生物制品学、生物化学实验、有机化学实验和生物工程大实验等理论和实验课程。
主要研究领域：1）生物酶催化；2）DNA纳米技术。
科研课题情况：1）主持衡水学院高层次人才科研启动基金项目1项；2）主持河北省高等学校科学技术研究项目1项；3）主持衡水市科技计划项目1项；4）参与国家自然科学基金面上项目1项；5）参与河北省自然科学基金面上项目2项；6）参与石家庄市重点研发计划项目1项；7）参与申请国家发明专利4项，其中2项已授权。
论文发表情况：在International Journal of Nanomedicine，Nanomaterials，Ceramics International，RSC Advances，Scientific Reports，Green Chemistry，Letters in Applied Microbiology，Journal of Applied Microbiology，Biotechnology Letters，微生物学报，应用与环境微生物学报等期刊上发表论文近20篇，其中SCI 论文10余篇。
1. Chao Zhang, Fanghua Zhang, Mengnan Han, Xuming Wang, Jie Du, Honglei Zhang, Wei Li*. Affibody modified G-quadruplex DNA micelles incorporating polymeric 5-fluorodeoxyuridine for targeted delivery of curcumin to enhance synergetic therapy of HER2 overexpressing gastric cancer. Nanomaterials (Basel). 2022, 12(4): 696.
2. Chao Zhang, Fanghua Zhang, Mengnan Han, Xuming Wang, Jie Du, Honglei Zhang and Wei Li*. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer. Scientific Reports, 2020, 10: 22015.
3. Chao Zhang, Mengnan Han, Fanghua Zhang, Xueli Yang, Jie Du, Honglei Zhang, Shengxi Chen, Wei Li*. Enhancing antitumor efficacy of nucleoside analog 5-fluorodeoxyuridine on HER2-overexpressing breast cancer by affibody-engineered DNA nanoparticle. International Journal of Nanomedicine. 2020, 15: 885-900.
4. Chao Zhang, Jinping Lan, Shuo Wang, Shuguang Han, Hao Yang, Qimeng Niu, Jing Wang, Qianqian Wang, Yuhong Xiang, Yuwei Wua, Xuejiao Zhang, He Lin, Xiaoyun Zhang, Haixia Qiao, Yong Huang*. Silver nanowires on acid-alkali-treated titanium surface: Bacterial attachment and osteogenic activity. Ceramics International. 2019, 45(18): 24528-24537.
5. Haixia Qiao, Chao Zhang(共同第一作者), Xianyang Dang, Hao Yang, Yirao Wang, Yunlong Chen, Lifei Ma, Shuguang Han, He Lin, Xuejiao Zhang, Jinping Lan, Yong Huang*. Gallium loading into a polydopamine-functionalised SrTiO3 nanotube with combined osteoinductive and antimicrobial activities. Ceramics International. 2019, 45(17): 22183-22195.
6. Chao Zhang, HongLei Zhang, MengNan Han, XueLi Yang, ChaoHong Pei, ZhiDong Xu, Jie Du, Wei Li, Shengxi Chen. DNA–affibody nanoparticle delivery system for cisplatin-based breast cancer chemotherapy. RSC Advances, 2019, 9(4):1982-1989.
7. Honglei Zhang, Chao Zhang, Mengnan Han, Chaohong Pei, Zhidong Xu, and Wei Li*. Efficient biosynthesis of enantiopure tolvaptan by utilizing alcohol dehydrogenase-catalyzed enantioselective reduction. Green Chemistry. 2018, 20(6): 1224-1227.
8. Honglei Zhang, Chao Zhang, Chaohong Pei, Mengnan Han, Zhidong Xu, Cunhui Li, Wei Li*. Efficient production of trans-4-Hydroxy-L-proline from glucose by metabolic engineering of recombinant Escherichia Coli. Letters in Applied Microbiology. 2018, 66(5): 400-408.
9. HongLei Zhang, Chao Zhang, Chao-Hong Pei, Meng-Nan Han, Zhi-Dong Xu and Wei Li*. Enantioselective synthesis of enantiopure chiral alcohols using carbonyl reductases screened from Yarrowia lipolytica. Journal of Applied Microbiology. 2018,126 (1): 127-137.
10. YanLiu, TuoxianTang, Xiaoqiong Pei, Chao Zhang, Zhongliu Wu*. Identification of ketone reductase ChKRED20 from the genome of Chryseobacterium sp. CA49 for highly efficient anti-Prelog reduction of 3,5-bis(trifluoromethyl)acetophenone. Journal of Molecular Catalysis B: Enzymatic. 2014, 102(4), 1-8.
11. Chuangen Tang, Hui Lin, Chao Zhang, Zhangqin Liu, Tao Yang, Zhongliu Wu*. Highly enantioselective bioreduction of N-methyl-3-oxo-3-(thiophen-2-yl) propanamide for the production of (S)-duloxetine. Biotechnology Letters. 2011, 33(7): 1435-1440.
